191 related articles for article (PubMed ID: 36401602)
1. Identification of core genes in prefrontal cortex and hippocampus of Alzheimer's disease based on mRNA-miRNA network.
Huang ZH; Wang H; Wang DM; Zhao XY; Liu WW; Zhong X; He DM; Mu BR; Lu MH
J Cell Mol Med; 2022 Dec; 26(23):5779-5793. PubMed ID: 36401602
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease.
Li H; Zou L; Shi J; Han X
Hereditas; 2021 Jul; 158(1):25. PubMed ID: 34243818
[TBL] [Abstract][Full Text] [Related]
3. Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.
Li J; Xu C; Zhang J; Jin C; Shi X; Zhang C; Jia S; Xu J; Gui X; Xing L; Lu L; Xu L
Neurochem Res; 2021 Apr; 46(4):964-979. PubMed ID: 33586092
[TBL] [Abstract][Full Text] [Related]
4. The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.
Pang X; Zhao Y; Wang J; Zhou Q; Xu L; Kang D; Liu AL; Du GH
Biomed Res Int; 2017; 2017():9084507. PubMed ID: 29359159
[TBL] [Abstract][Full Text] [Related]
5. Identification of Key Regulatory Genes and Pathways in Prefrontal Cortex of Alzheimer's Disease.
Yang F; Diao X; Wang F; Wang Q; Sun J; Zhou Y; Xie J
Interdiscip Sci; 2020 Mar; 12(1):90-98. PubMed ID: 32006383
[TBL] [Abstract][Full Text] [Related]
6. Identification of dysregulated genes and pathways of different brain regions in Alzheimer's disease.
Wang Y; Wang Z
Int J Neurosci; 2020 Nov; 130(11):1082-1094. PubMed ID: 32019384
[No Abstract] [Full Text] [Related]
7. Identification of Immune Cells and Key Genes associated with Alzheimer's Disease.
Liu C; Zhang X; Chai H; Xu S; Liu Q; Luo Y; Li S
Int J Med Sci; 2022; 19(1):112-125. PubMed ID: 34975305
[TBL] [Abstract][Full Text] [Related]
8. Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology.
Noh H; Park C; Park S; Lee YS; Cho SY; Seo H
BMC Genomics; 2014 Aug; 15(1):644. PubMed ID: 25086961
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of miRNA and mRNA expression in the blood of patients with Alzheimer's disease.
Wang Z; Shen L; Wang Y; Huang S
Mol Med Rep; 2020 Aug; 22(2):1053-1062. PubMed ID: 32468026
[TBL] [Abstract][Full Text] [Related]
10. The Relationship between the Aberrant Long Non-Coding RNA-Mediated Competitive Endogenous RNA Network and Alzheimer's Disease Pathogenesis.
Cai Z; Zhao K; Zeng L; Liu M; Sun T; Li Z; Liu R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955632
[TBL] [Abstract][Full Text] [Related]
11. Identification of altered exosomal microRNAs and mRNAs in Alzheimer's disease.
Su L; Li R; Zhang Z; Liu J; Du J; Wei H
Ageing Res Rev; 2022 Jan; 73():101497. PubMed ID: 34710587
[TBL] [Abstract][Full Text] [Related]
12. Integrated identification of key genes and pathways in Alzheimer's disease via comprehensive bioinformatical analyses.
Yan T; Ding F; Zhao Y
Hereditas; 2019; 156():25. PubMed ID: 31346329
[TBL] [Abstract][Full Text] [Related]
13. Immune-Related Hub Genes and the Competitive Endogenous RNA Network in Alzheimer's Disease.
Xu H; Jia J
J Alzheimers Dis; 2020; 77(3):1255-1265. PubMed ID: 32925027
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of mRNAs in the Brain Tissues of Patients with Alzheimer's Disease Based on GEO Expression Profile and Its Clinical Significance.
Ma G; Liu M; Du K; Zhong X; Gong S; Jiao L; Wei M
Biomed Res Int; 2019; 2019():8179145. PubMed ID: 30918899
[TBL] [Abstract][Full Text] [Related]
15. Key gene network related to primary ciliary dyskinesia in hippocampus of patients with Alzheimer's disease revealed by weighted gene co-expression network analysis.
Xia P; Chen J; Bai X; Li M; Wang L; Lu Z
BMC Neurol; 2022 May; 22(1):198. PubMed ID: 35637434
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic Analysis and Experimental Validation of Ubiquitin-Proteasomal System-Related Hub Genes as Novel Biomarkers for Alzheimer's Disease.
Zhang Y; Wu J; You G; Guo W; Wang Y; Yu Z; Geng Y; Zhong Q; Zan J; Zheng L
J Integr Neurosci; 2023 Oct; 22(6):138. PubMed ID: 38176925
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease.
Chang WS; Wang YH; Zhu XT; Wu CJ
Med Sci Monit; 2017 Jun; 23():2721-2731. PubMed ID: 28578378
[TBL] [Abstract][Full Text] [Related]
18. Identification of key lipid metabolism-related genes in Alzheimer's disease.
Zeng Y; Cao S; Li N; Tang J; Lin G
Lipids Health Dis; 2023 Sep; 22(1):155. PubMed ID: 37736681
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of miRNA-mRNA regulatory network and potential drugs in chronic chagasic cardiomyopathy across human and mouse.
Wu J; Cao J; Fan Y; Li C; Hu X
BMC Med Genomics; 2021 Nov; 14(1):283. PubMed ID: 34844599
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
